Short Wave How Effective Are Antibody Treatments For COVID-19?
Dec 7, 2020
Richard Harris, a seasoned science correspondent, delves into the world of monoclonal antibody treatments for COVID-19. He discusses the FDA's emergency use authorizations for therapies from Eli Lilly and Regeneron, explaining that while these treatments are promising, their effectiveness isn't guaranteed. Harris breaks down how these antibodies function, their role in treating high-risk patients, and the logistical challenges they face. The conversation also highlights the comparison between monoclonal antibodies and vaccines in the broader fight against the pandemic.
AI Snips
Chapters
Transcript
Episode notes
Who Benefits from Monoclonal Antibodies?
- The treatment is for people recently diagnosed with COVID-19 with mild to moderate symptoms.
- Those most likely to benefit are older patients and people with underlying conditions.
How Monoclonal Antibodies Work
- Monoclonal antibodies target and neutralize the coronavirus.
- They work by latching onto the virus's binding spot, preventing it from invading cells.
Hospital Logistics for Monoclonal Antibody Treatment
- MedStar Hospitals in Washington, D.C., escorts patients to and from the dedicated infusion center.
- This prevents them from wandering around the hospital and potentially spreading the virus.